Newsletter Archive

  1. 10.01.14 -- Scripps Researchers Create New Classes Of Antibiotics; Analytical QbD At Teva
    10/1/2014

    10/01/14 BioProcess Online Newsletter

  2. 09.29.14 -- Merck KGaA To Acquire Sigma-Aldrich For $17B; Gilead's HIV Regimen Pulls Weight In Phase 3 Studies
    9/29/2014

    09/29/14 BioProcess Online Newsletter

  3. 09.24.14 -- Pfizer, MedGenesis Team Up; Puerto Rico To Be New Hub For HIV Vaccine R&D
    9/24/2014

    09/24/14 BioProcess Online Newsletter

  4. 09.22.14 -- Best Practices In Biomanufacturing Supplier Relations: Reducing Raw Materials Risks
    9/22/2014

    09/22/14 BioProcess Online Newsletter

  5. 09.18.14 -- Genmab And Seattle Genetics Expand ADC Collaboration; When To Invest In Protein Production
    9/18/2014

    09/18/14 BioProcess Online Newsletter

  6. 09.15.14 -- GSK Discusses The Transformation Of Biopharmaceutical Manufacturing: Single-Use Is Only Part Of The Strategy
    9/15/2014

    09/15/14 Bioresearch Online Newsletter

  7. 09.10.14 -- AstraZeneca And Redx Ink R&D Deal On Tumor Genetics; QbD at Genentech
    9/10/2014

    09/10/14 Bioresearch Online Newsletter

  8. 09.08.14 -- Merck And Advaxis Partner; FDA Fast Tracks VentiRx's Immunotherapy For Ovarian Cancer
    9/8/2014

    09/08/14 Bioresearch Online Newsletter

  9. 09.03.14 -- Proteins That Promote HIV/Ebola Virus Also Inhibit Release; Antitope To Partner With UCL In Antibody Project
    9/3/2014

    09/03/14 Bioresearch Online Newsletter

  10. 09.01.14 -- Patheon Surfs Outsourcing Waves And Scoops Up Gallus Along The Way
    9/1/2014

    09/01/14 Bioresearch Online Newsletter

Newsletter Signup
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.